Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Market Cap : $0.00 Mil (As of Jun. 06, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Parnell Pharmaceuticals Holdings's share price for the quarter that ended in Dec. 2018 was $0.16. Parnell Pharmaceuticals Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2018 was 18.03 Mil. Therefore, Parnell Pharmaceuticals Holdings's market cap for the quarter that ended in Dec. 2018 was $2.88 Mil.

Parnell Pharmaceuticals Holdings's quarterly market cap declined from Dec. 2016 ($12.52 Mil) to Dec. 2017 ($10.89 Mil) and declined from Dec. 2017 ($10.89 Mil) to Dec. 2018 ($2.88 Mil).

Parnell Pharmaceuticals Holdings's annual market cap declined from Dec. 2016 ($12.52 Mil) to Dec. 2017 ($10.89 Mil) and declined from Dec. 2017 ($10.89 Mil) to Dec. 2018 ($2.88 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Parnell Pharmaceuticals Holdings's Enterprise Value for Today is $0.00 Mil.

Parnell Pharmaceuticals Holdings Market Cap Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Market Cap Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Market Cap

Get a 7-Day Free Trial

91.66

51.54

12.52

10.89

2.88

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Market Cap	Get a 7-Day Free Trial			91.66	51.54	12.52	10.89	2.88

Competitive Comparison of Parnell Pharmaceuticals Holdings's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnell Pharmaceuticals Holdings's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's Market Cap falls into.

Parnell Pharmaceuticals Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Parnell Pharmaceuticals Holdings's Market Cap for the fiscal year that ended in Dec. 2018 is calculated as

Market Cap (A: Dec. 2018 )	=	Share Price (A: Dec. 2018 )	*	Shares Outstanding (EOP) (A: Dec. 2018 )
	=	$0.16	*	18.027
	=	$2.88

Parnell Pharmaceuticals Holdings's Market Cap for the quarter that ended in Dec. 2018 is calculated as

Market Cap (Q: Dec. 2018 )	=	Share Price (Q: Dec. 2018 )	*	Shares Outstanding (EOP) (Q: Dec. 2018 )
	=	$0.16	*	18.027
	=	$2.88

Parnell Pharmaceuticals Holdings (OTCPK:PARNF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Parnell Pharmaceuticals Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.